R

RLAY

RLAY

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
RLAY Live QuoteReal-time
$16.12
$2.22(-12.10%)1M
Day Range$15.17 – $16.32
Open$15.59
Previous Close$15.91
Volume3.97M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.52B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-1.44
Price to Book4.5
Dividend Yield0.65%
Beta (Volatility)1.74
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $16.12 (64%)
Low: $6.80High: $21.27
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$28.25-81.2% upside

Insider Buys

0

$0

Insider Sales

3

$83K

Total Volume

$83K

3 transactions

Net Activity

$83K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
B
1

Bergstrom Donald A

Pres, R, D

0 buys1 sells

$42K total

C
2

Catinazzo Thomas

CFO

0 buys1 sells

$27K total

R
3

Rahmer Peter

See remarks

0 buys1 sells

$14K total

Trading History
RLAY insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 28, 2026

3 weeks ago

Rahmer Peter

See remarks

Insider
Sell753$18.62$14K

Oct 28, 2026

3 weeks ago

Bergstrom Donald A

Pres, R, D

President
Sell2.3K$18.62$42K

Oct 28, 2026

3 weeks ago

Catinazzo Thomas

CFO

CFO
Sell1.5K$18.62$27K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
RLAY Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.51B

RLAY has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for RLAY

Over the last 90 days, corporate insiders at RLAY (RLAY) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $83K.

The net insider activity for RLAY shows a net selling bias of $83K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Bergstrom Donald A (Pres, R, D), who traded 2.3K shares valued at $42K on Oct 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for RLAY (RLAY)
6 updates

RLAY - Relay Therapeutics Inc Stock Price and Quote

Finviz177d ago

Relay Therapeutics Announces Proposed Public Offering of Common Stock

Yahoo Finance185d ago

Understanding the Setup: (RLAY) and Scalable Risk

Stock Traders Daily3d ago

Relay Therapeutics: Zovegalisib Is Becoming A Platform In Disguise (NASDAQ:RLAY)

Seeking Alpha184d ago

This Biotech's Drug Just Wiped The Floor With Forecasts

Investor's Business Daily185d ago

Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run

Simply Wall St93d ago

FAQs About RLAY Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for RLAY.

Based on SEC Form 4 disclosures, the Insider Confidence Score for RLAY is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 3 sales by company executives over the last 90 days.

The CEO Conviction Index for RLAY is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.